Retatrutide and 5-Amino-1MQ: Evidence, Safety, and UK Regulatory Status Retatrutide and 5-Amino-1MQ are two compounds generating considerable interest in metabolic health and weight management circles, yet neither holds a marketing authorisation in the UK
When NNMT activity is inhibited, these methyl donors become available for other methylation reactions in the body
Independent, third-party testing for identity and purity is the standard that separates a medical-grade compound from a bag of powder with a label
Stacking multiple GLP-1 agonists together, such as semaglutide and tirzepatide, is generally not recommended due to overlapping mechanisms and increased side effect risk
When NNMT activity is high, fat cells become more efficient at lipogenesis, the process of creating and storing fat